In May 2026, HHS announced its most ambitious Lyme disease initiative yet, funding tick control, faster diagnostics, and new research into tick-related conditions. Several parts of that plan are still actively unfolding through this summer, which means the news is still relevant if you or someone you love has spent years chasing answers for persistent symptoms after a tick bite.
If you live with Lyme disease or a related chronic condition, the news matters. So does understanding where conventional efforts stop and where functional medicine picks up.
Why this is a turning point
Lyme disease is one of the fastest-growing vector-borne health threats in the country. More than 476,000 Americans are diagnosed each year, and recent data show emergency room visits for tick bites hit their highest springtime level in nearly a decade.
HHS set a clear target: cut Lyme disease cases by 25 percent by 2035, measured against 2022 levels. To get there, the agency is funding research, prevention, and faster diagnosis on several fronts at once.
What the plan includes
The announcement covers four main efforts:
A tick-control pilot program. Led by the CDC and HHS alongside leading researchers, this multi-million-dollar program aims to target and eliminate ticks on wildlife before they reach humans. The work starts with the New England Center of Excellence in Vector-Borne Diseases and builds on community collaboration, including the Indian Health Service and the Wampanoag Tribe in Massachusetts.
Innovation challenges. HHS rolled out three new LymeX challenges with up to $2.5 million in total prize funding, aimed at public awareness, frontline treatment ideas, and using AI to help patients with Lyme and other invisible illnesses get answers faster. The Healthathon portion of that effort is still taking submissions through August 7, 2026, so this isn’t a closed chapter — it’s actively developing.
Alpha-gal syndrome research. NIH is funding new work on Alpha-gal syndrome, a tick-associated condition that can trigger serious allergic reactions to red meat and other mammalian products. CDC estimates nearly 500,000 Americans live with it, and emerging evidence suggests the real number may be higher.
A renewed focus on experienced care. HHS underscored the importance of connecting patients with providers who specialize in Lyme disease and associated chronic conditions. It is a clear acknowledgment that complex, lingering cases call for clinicians who treat them often, not occasionally.
HHS also continues to back research at scale, with NIH investing nearly $50 million a year in Lyme disease research and about $122 million a year across broader tick-borne disease work.
The diagnosis problem
One of the hardest parts of Lyme disease is getting an accurate diagnosis. Standard testing has long struggled with early and late-stage cases, which is part of why so many people go years without clear answers.
HHS is pushing on this directly. Through LymeX, it launched a $10 million Diagnostics Prize to accelerate faster, more accurate next-generation tests. Two improved FDA-cleared Lyme diagnostics have already reached the market through that ecosystem.
Where functional medicine comes in
Federal investment in prevention, diagnostics, and research is meaningful progress. But the patients HHS describes, the ones who have spent years looking for support, often need something the acute model is not built to provide: care for what happens after the tick bite, when symptoms linger and standard treatment has run its course.
That is the gap functional medicine is designed to address.
At Forum Health, our functional medicine approach to Lyme and chronic tick-borne illness looks at the whole person rather than a single test result. That means investigating the factors that influence how the body responds to infection, including immune function, chronic inflammation, gut health, detoxification capacity, and the presence of co-infections that often travel with Lyme. The goal is to identify and address the root drivers of symptoms, not just manage them in isolation.
For many patients, this whole-person model is what finally connects the dots after years of being told their labs look normal.
What to do with this news
If you are dealing with persistent symptoms after a tick bite, or you suspect Lyme is behind issues that have never been fully explained, this is a good moment to take the next step. Our functional medicine providers work with patients navigating Lyme disease and associated chronic conditions every day. If you are ready for a more complete picture of what is happening in your body, we are here to help.
Frequently asked questions
What is Alpha-gal syndrome, and how is it connected to Lyme disease?
Alpha-gal syndrome is an allergic condition triggered by certain tick bites, most commonly from the lone star tick. It causes reactions to red meat and other mammalian products, ranging from mild to severe. It isn’t Lyme disease itself, but it’s part of the same broader picture of tick-borne conditions that HHS’s initiative is investing in, and it’s often overlooked by standard diagnostic pathways the same way chronic Lyme symptoms can be.
How is functional medicine different from standard treatment for tick-borne illness?
Standard care typically focuses on identifying and treating an active infection, which works well for many people. Functional medicine is built for what comes next: patients whose symptoms persist after treatment, or whose testing never produced a clear answer. Rather than looking at a single marker, a functional medicine provider looks at immune function, inflammation, gut health, and co-infections together to find what’s actually driving ongoing symptoms.
Federal diagnostics are improving. Does that mean I should wait for a better test before seeking care?
Not necessarily. Better diagnostics are a meaningful step forward, and two improved FDA-cleared tests are already available. But if you’re already dealing with persistent symptoms, waiting on future testing shouldn’t delay getting support now. A functional medicine provider can start investigating root causes with the tools available today.
